Tofacitinib, an oral Janus kinase inhibitor, in patients from Mexico with rheumatoid arthritis: Pooled efficacy and safety analyses from Phase 3 and LTE studies
Title:
Tofacitinib, an oral Janus kinase inhibitor, in patients from Mexico with rheumatoid arthritis: Pooled efficacy and safety analyses from Phase 3 and LTE studies
Author:
Burgos-Vargas, Ruben Cardiel, Mario Xibillèc), Daniel Pacheco-Tena, Cèc)sar Pascual-Ramos, Virginia Abud-Mendoza, Carlos Mahgoub, Ehab Rahman, Mahboob Fan, Haiyun Rojo, Ricardo García, Erika Santana, Karina
Appeared in:
Reumatologia clinica (English edition)
Paging:
Volume 15 (2019) nr. 1 pages 43-53
Year:
2019
Contents:
Publisher:
Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología